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Background: Preventing diabetic foot problems (DFP) and their associated consequences is a critical in rural
regions. The objective is to present an association of non-invasive DFP assessment tools and physiological
indicators for early detection among rural cases of diabetes in Taiwan.
Methods: Secondary data analysis of 387 participants previously diagnosed with type 2 diabetes was used. The
Michigan Neuropathy Screening Instrument (MNSI), Ankle Brachial Index (ABI), optimal scaling combination (OSC) of
MNSI, and age were used to examine peripheral neurovascular function. The King’s College classification (KC) and
Texas risk classification (TRC) were used to understand diabetic foot complications.
Results: The findings indicated that MNSI was negatively correlated with ABI, but positively with diabetes duration,
age, KC, TRC, fasting blood glucose, low density of lipoprotein cholesterol, body mass index and waist
circumference. The area under the receiver operating characteristic curves for assessing the risk of ABI based on
OSC was larger than for MNSI, KC, and TRC.
Conclusion: It is shown that using OSC, MNSI, and ABI as community screening tools is useful in detecting early
neurovasculopathy. In addition, where an ABI machine is unavailable, primary healthcare providers that perform
MNSI or OSC may be cost-effective. The study was approved by the institutional review board of the ethical
committee (No 98-2224-B).
Keywords: Diabetic foot problems, Michigan neuropathy screening instrument, Ankle brachial index, Receiver
operating characteristic curvesBackground
According to ICD-10, diabetes is the fifth most common
cause of death, accounting for 35 deaths per 100,000
persons in 2008 [1]. The standardized mortality rate of
diabetes in Taiwan is higher than that in the United
States (14/100,000) and Japan (4/100,000). Diabetic foot
ulcers occur in up to 25% of people with diabetes at
some time in their life [2,3]. Diabetic foot problems
(DFP) are a common cause of hospitalization world-
wide, and are associated with lower limb amputation
[1,4,5]. Sensory neuropathy is commonly associated
with foot ulcers due to the loss of protective sensation.* Correspondence: meiyen@gw.cgust.edu.tw
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reproduction in any medium, provided the orIt is estimated that 45-60% of diabetic foot ulcers are
purely neuropathic [6]. The mechanism of diabetic neur-
opathy may be associated with a decrease in myelinated
fiber density, as hyperglycemia induces microvascular
complications and loss or degeneration of nerve fibers.
Peripheral arterial disease is a risk factor associated with
diabetes foot complications, along with neuropathy, foot
deformity, and infection [5,7]. DFP can be prevented via
early screening and prompt treatment of peripheral neur-
opathy and vasculopathy [8]. Early symptoms are easily
overlooked as this condition develops slowly [9]. Without
adequate management, there is a high risk of infection
and death among patients suffering from DFP. However,
early prevention of DFP is often neglected in primary care
settings in Taiwan, except in acute care settings.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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opathy and peripheral circulation is important for dia-
betics, particularly among the rural elderly [9]. There are
some efficient, inexpensive, and non-invasive measure-
ment tools, such as monofilament and the vibration per-
ception test that can assess peripheral sensory neuropathy
[10,11]. MNSI is a reliable and valid scale for detecting
diabetic neuropathy as reported [12]. However, it was not
popularly used in primary health care settings. Further-
more, assessment of pedal pulses is a simple but valuable
test to evaluate vasculopathy. Absent pedal pulses are evi-
dence of peripheral vascular disease, even in asymptom-
atic patients [13,14]. Skin capillary circulation is more
impaired in the toes of diabetic than non-diabetic patients
with peripheral vascular disease [15]. Boyko et al. even
suggested capillary refill time conveyed little diagnostic
information and was omitted from routine foot examina-
tions [16]. However, recently, study still stated that delayed
capillary refill is indicative of ischemic disease. They re-
ferred increased capillary refill as a sign of venous insuffi-
ciency or obstruction [17]. Erasmus (2008) proposed that
capillary refill time could be used to assess the perfusion
of tissues in the feet [18]. In addition, KC has been used to
focus on the development of foot ulcers [8,19]. It provides
a management plan based on six stages of the condition.
TRC uses risk factors that include the existence of ulcer-
ation, infection, Charcot foot, the degree of foot deformity
and joint mobility, and the level of peripheral neuropathy
and vascular together classify diabetic foot ulcer risks [20].
This provided a corresponding level of foot care according
to eight categories. Previous studies have stated that TRC
categories are highly associated with the increased risk of
amputation and prolonged ulcer healing time [20,21]. In
addition, ABI is used to assess blood flow and classify ar-
terial disease [22,23]. The index is calculated by dividing
the highest systolic pressure from the two pedal arteries
by the brachial systolic pressure [4]. Values <0.9 were indi-
cative of peripheral arterial disease [24]. Although ABI is a
useful objective variable to assess DFP, an ABI machine is
expensive (for example, the Cardio-Vision Model MS-
2000 used in this study was ~$20,000).
There is good evidence that controlling blood glucose,
pressure, and lipids can markedly reduce the adverse
effects of diabetes and are substantially beneficial [25].
According to the recommendations for the target of dia-
betes treatment of the Taiwan Department of Health and
authority organizations, the criteria for glycemic, lipid,
and blood pressure measures [1,26] are fasting blood
glucose <130 mg/dl, total cholesterol (TC) <175 mg/dl,
and blood pressure <130/85 mmHg. As noted in previ-
ous study [27], they indicate that the prevalence of neur-
opathy increased with age. However, reports about the
efficient community screening tools used for detection
of the early stages of neurovasculopathy are limited.MNSI is a clinical scoring system developed as a quanti-
tative instrument to document the presence and severity
of diabetic peripheral neuropathy.
In accordance with the literature, we explore the rela-
tionship between MNSI, ABI, and health-related indica-
tors among diabetes in the Western coastal region in
Taiwan. Furthermore, we assessed whether the applica-
tion of MNSI or a new index, based on the optimal scal-
ing combination of MNSI and age (OSC), increases the
area under ROC curves (AUCs) for assessing the risk of
DFP in the elderly in Taiwan compared to KC and TRC.
We hypothesized that MNSI or OSC is more signifi-
cantly associated with the results of ABI evaluation than
KC and TRC. Finally, we attempted to determine the
cut-off points of MNSI and OSC for the diagnosis of
DFP in the elderly.
Methods
Sample and setting
This study was part of a longitudinal cohort study of
HPDMF (health promotion for preventing T2DM foot
among rural community residents, 2009~2011) in the
southwestern coastal Chia-Yi County. The original study
adopted a multi-disciplinary team approach, including
12 certified nurses (three diabetes educators and nine
public health nurses) and three senior doctors (an endo-
crinologist and plastic surgeons qualified for DM foot
prevention and wound care). All research assistants and
researchers (including the physicians and statistician)
were given a three-day (eight-hour) training program
including assessment procedures, familiarity with instru-
ments, health promotion counseling techniques, and
how to administer a structured interview. All partici-
pants received a three-stage professional health assess-
ment over a one-year period. In this paper, we used
secondary data analysis. Data were obtained from the
first year study (2009). It included 387 Taiwanese com-
munity residents with T2DM, randomly selected from
the local diabetes registration files by the public health
nurses in each district. Simple random sampling from
their local DM registration files was used by the PHNs
in each of the nine districts. Selection criteria included
subjects who: (1) were diagnosed as T2DM by a phys-
ician (2) had a stable physical condition with fasting glu-
cose level less than 300 mg/dl and (3) were willing to
participate in the study. Exclusion criteria were: (1) ser-
ious mental problems (2) serious complications of DM
and (3) inability to walk to a local health center. On
average, each district selected 40~50 participants.
Instruments
(1) Peripheral neurological assessment was carried out
using MNSI as previously described [18]. The diabetes
nurse educators assessed five variables on both feet and
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ance of feet, if abnormal, then inspection of lower limbs
for deformities, dry skin, fissure, calluses, or infection was
carried out; (2) Identification of foot ulceration; (3) Vibra-
tion perception threshold testing - semi-quantitative as-
sessment of vibration sensation was conducted with a
128-Hz turning fork on the dorsum of the big toe. Pa-
tients, whose eyes are closed, will be asked to indicate
when they can no longer sense the vibration from the
vibrating tuning fork. (4) Ankle reflexes were examined by
tapping the Achilles tendon with a hammer; and (5)
Touch-pressure sensation test with a 5.07/10 g Semmes-
Weinstein monofilament by applying the monofilament
perpendicular to the test sites of feet. The patients with
closed eyes were asked to respond yes if they felt the fila-
ment. For this examination, it is important that the pa-
tient’s foot be supported (e.g. allow the sole of the foot to
rest on a flat, warm surface). Abnormality was determined
by the number of positive responses or abnormal clinical
findings. Eight correct responses out of the 10 applications
are considered as normal. A MNSI score greater than 2
(10-point scale) was considered neuropathic in this project
and patients were referred to teaching hospitals for further
evaluation [28]. According to Booth and Young [29], only
70% of the Semmes-Weinstein monofilaments buckled
within +/−1.0 g of 10 g. Although Semmes-Weinstein
monofilaments were not a perfect instrument, it was
popularly used in Taiwan. Further research is necessary to
validate the test. The MNSI procedure took 6–8 minutes
for each participant.
(2) Peripheral vascular assessment: three variables
were used to assess peripheral vascular function by trained
nurses. (a) The Cardio-Vision Model MS-2000 was used
to detect ABI, assessed by research nurses. ABI was calcu-
lated from ankle pressure/arm pressure. A low ankle-arm
index is a good marker of vascular disease. Values of ABI
were classified as ≥0.9 normal and <0.9 abnormal [24].
The ABI test is a popular tool for the non-invasive assess-
ment of peripheral arterial disease with many supported
data in the past. It is known to be unreliable on patients
with arterial calcification and results in less or incompress-
ible arteries, which is often found in patients with diabetes.
Nevertheless, the ABI is a fast and painless exam with
quantitative ratio presentation rather than manual meas-
urement. (b) Palpable pedal, posterior tibias, and popliteal
pulses were recorded as absent, weak or present. (c) Capil-
lary refill time was done by pressing the tip of the toenail
for two seconds, and taking the time for the blanched area
to turn pink again. If the return time took >2 seconds, this
was taken as ischemia. Assessing of all three variables of
peripheral vascular assessment took 10–15 minutes for
each participant.
(3) Diabetic foot risk assessment was assessed by plas-
tic surgeons: (a) KC contained six stages of condition:not at risk, at risk, ulcer, cellulites, necrosis, and ampu-
tation [19]. (b) The TRC system was divided into six
categories in origin [20]. We re-categorized three levels:
low risk, at risk, and high risk because in a community
settings, most of the participants were categorized in the
first two levels.
(4) The blood glucose, TC, and low density of lipopro-
tein cholesterol (LDL) were drawn from the last 1–2
month diabetes passport record for each participant.
Blood pressure was measured according to standard pro-
cedures by nurses during the study. BMI was calculated
for each participant using the standard formula (weight
in kilograms divided by square of the height in meters).
Waist circumference (WC) in centimeters were used to
measure central obesity, measuring the mid-abdominal
distance between the last rib margin and the iliac crest.
(5) OSC, the optimal scaling combination of MNSI
and age, which was derived from a logistic regression
model.
Procedure and ethical considerations
The study was approved by the institutional review
board of the ethical committee (No 98-2224-B). In-
formed consent was obtained from all participants. Par-
ticipants were notified about the survey by public health
nurses and had the opportunity to review the question-
naire and indicate if they did not want to participate in
this study. For ethical reasons, a cover letter was sent
with the questionnaire, emphasizing that the responses
are confidential. During the data analysis, confidentiality
was maintained by data coding.
Analysis
SPSS (Version 14.0) was used for data analyses. All tests
were 2-sided and p-values <0.05 were considered statisti-
cally significant. Categorical data analyses (chi-square
test, odds ratios and 95% confidence intervals) were
applied to identify the association of MNSI, ABI and
health-related indicators. Of the 391 participants se-
lected, 387 completed the study. Missing data were ex-
cluded from analysis. Four of the missing data included
2 participants were type1 diabetes and 2 participants un-
completed biomarkers were examined. OSC was derived
from a logistic regression model. The formula of OSC
was taken as Eq. (1)
OSC ¼ 0:1 ageþ 0:2MNSI ð1Þ
We computed the AUCs for the identification of the
results of ABI evaluation by using KC, TRC, MNSI, and
OSC to evaluate the index that had the highest associ-
ation with the results of ABI evaluation. The area test
has been applied to test the equality of ROC curves [30].
Based on the significance of the p-values from the area
Table 1 Demographic characteristics (N=387)
Variables Mean (SD, Range) N %
Age (year) 68.7 (9.4, 27~ 90)
Duration of diabetes year 7.9 (6.2, 0.5~33)





No 36 ( 9.3)
Adopted insulin injection





missing 26 ( 6.7)
HbA1C




Normal (~24) 118 (30.5)
Overweight (~27) 123 (31.8)
Obesity (>27) 146 (37.7)
Waist circumference (cm)
Normal (male≦90, female≦80) 129 (33.3)
Abnormal (male≧91, female≧81) 258 (66.7)
Michigan Neuropathy Screening score
≦3.0 301 (77.8)
≧3.5 86 (22.2)
ABPI (ankle brachial pressure index)
≧ 0.90 338 (87.3)













Table 1 Demographic characteristics (N=387) (Continued)
Oral care (Brush after meal )
Yes 129 (33.3)
No 258 (66.7)
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ABI evaluation in terms of sensitivity and specificity. An
MNSI score of 2, KC of 2, and TRC of 2 (based on a
previous study) were taken as cut-off values [19,20,28].
The optimal cut-off value of OSC, MNSI, KC, and TRC




1−sensitivityð Þ2 þ 1−specificityð Þ2
q 
:
ð2ÞTable 2 The relationship between MNSI, ABI and health-
related physiological indicators
MNSIa ABI
Right side Left side
ABIb
Right side ABI -.19***
Left side ABI -.17*** .80***
DM duration (years) .12* - .10* - .14**
Age .29*** -.23*** -.19***
King’s college classification .58*** -.29*** -.26***
Texas risk classificationc .72*** -.25*** -.23***
Systolic blood pressure .07 -.17** -.15**
Diastolic blood pressure .01 .01 .03
Blood glucose .14** -.03 -.02
TC .10 -.07 -.09
LDL .25*** - .05 -.12*
Body mass index .11* .10 .09
Waist circumference .22*** .03 -.03
a MNSI Michigan neuropathy screening instrument b ABI Ankle brachial index
c Texas risk classification: University of Texas diabetic foot risk classification
*p < .05, ** p<.01, ***p < .001.
Table 3 The relationship between MNSI and health-related physiological indicators
Variables MNSIa χ2 Odds ratio 95%
Normal Abnormal
N (%) (d.f.=1) Confidence interval
Gender
Female 141 (62.1) 86 (37.9) 6.49** 1.70 1.13~2.57
Male 78 (49.1) 81 (50.9)
Education
<= primary school 162 (52.1) 149 (47.9) 14.07*** 0.34 0.19~0.61
>= secondary school 57 (76.0) 18 (24.0)
ABIb
Normal 198 (58.9) 138 (41.1) 5.10* 2.01 1.09~3.71
Abnormal 20 (41.7) 28 (58.3)
King’s college classificationc
Normal 179 (82.1) 39 (17.9) 129.90*** 14.33 8.75~23.47
Risk and high risk 41 (24.3) 128 (75.7)
Texas risk classificationd
Low risk 182 (96.3) 7 ( 3.7) 234.35*** 109.47 47.56~251.98
At/ or high risk 38 (19.2) 160 (80.8)
Right side dorsal pedal pulsese
Present/weakness 180 (60.2) 119 (39.8) 6.49* 1.86 1.15~3.01
Absent 39 (44.8) 48 (55.2)
Left side dorsal pedals pulses
Present/weakness 171 (60.9) 110 (39.1) 7.14** 1.85 1.17~2.90
Absent 48 (45.7) 57 (54.3)
Right side poster tibias pulses
Present/weakness 179 (59.1) 124 (40.9) 3.14 1.55 0.95~2.53
Absent 40 (48.2) 43 (51.8)
Left side poster tibias pulses
Present/weakness 174 (59.0) 121 (41.0) 2.58 1.47 0.92~2.36
Absent 45 (49.5) 46 (50.5)
Right side popliteal pulses
Present/weakness 163 (59.3) 112 (40.7) 2.51 1.43 0.92~2.23
Absent 56 (50.5) 55 (49.5)
Left side popliteal pulses
Present/ weakness 163 (59.1) 113 (40.9) 2.13 1.39 0.89~2.17
Absent 56 (50.9) 54 (49.1)
Right capillary refill time
<2 seconds 191 (59.5) 130 (40.5) 3.79 1.76 0.99~3.14
>2 seconds 25 (45.5) 30 (54.5)
Left capillary refill time
<2 seconds 190 (59.0) 132 (41.0) 2.61 1.61 0.90~2.89
>2 seconds 25 (47.2) 28 (52.8)
a MNSI Michigan Neuropathy Screening Instrument: normal <2 b ABI any side of ankle brachial index <0.9 was defined as abnormal. c King’s college classification:
in this table, except the level of not at risk, we re-categorized the other five conditions of at risk, ulcer, cellulites, necrosis and amputation as risk and high risk.
d University Texas risk classification system: in this table, we re-categorized the six conditions of at risk, ulcer, cellulites, necrosis and amputation as risk and high
risk. e Palpable pulses between both sides of dorsal pedals, poster tibias, and popliteal areas. *p < .05, ** p<.01, ***p < .001.
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Demographic and the relationship between MNSI, ABI,
and health-related indicators
A total of 59% of participants were female, the mean
age of the participants was 68.7 (±9.4) years. The aver-
age of diabetes duration since diagnosis was 8.17
(± 6.30) years (Table 1). Regarding to foot examination,
43.2 % of the participants (n = 140) had a MNSI > 2.0. In
addition, an ABI < 0.9 was noted in 10.8% participants
(n = 42). Tables 2 and 3 show the MNSI score was sig-
nificantly negatively associated with both sides of ABI.
In addition, MNSI was significantly positively associated
with diabetes duration, age, KC, TRC, blood glucose,
LDL, BMI, and WC. Figure 1 presents the plots of the
relationship.AUCs for the identification of the results of ABI with
MNSI, OSC, KC, and TRC
Table 4 shows the results of the area test. The area
under the ROC curve based on OSC was significantly
larger than the area based on MNSI (OSC vs. MNSI,
p < 0.05). However, the AUC based on MNSI was not
significantly different with the area based on KC (KC
vs. MNSI, p = 0.361) or TRC (TRC vs. MNSI, p =
0.69). These results imply that KC and TRC were not
significantly related to the results of ABI evaluation
than MNSI. However, OSC was more significantly re-
lated to the results of ABI evaluation than MNSI.
Figure 2 shows the ROC curves for the identification
of the results of ABI evaluation with OSC, MNSI, KC,
and TRC. Apparently, the AUC for OSC was higher
than that for MNSI, KC, and TRC. Table 4 shows the
sensitivity and specificity for the identification of the
results of ABI evaluation with cut-off values for MNSI,
OSC, KC, and TRC. The variables are arranged as
follows from high to low sensitivity: KC >1, TRC >1,
OSC ≥7.6, and MNSI ≥2. The variables are arranged as
follows from high to low specificity: OSC ≥7.6, KC >1,
TRC >1, and MNSI ≥2.Figure 1 Box plots of MNSI versus ABI, KC and TRC.Discussion
Peripheral vascular disease is a frequent long-term
complication and the principal cause for treatment of
hospitalized diabetic participants [31]. More specifically,
abnormal pressure distribution and sensory deficit are
the primary causes for diabetic patients developing foot
problems. Vascular damage with decreased oxygen sup-
ply to the peripheral nerves can lead to the death of
nerve tissues, adding to the development of these le-
sions. By taking nerve biopsies, a correlation between
the presence and the degree of microvascular abnormal-
ities with the presence and severity of diabetic neur-
opathy has already been reported [32,33].
Table 4 AUCs, area test, sensitivity, and specificity for the
prediction of the abnormal ABIa
AUC (95% C.I.) p-value for
area test
Sensitivity Specificity
MNSIb 0.660 (0.554, 0.765) - 0.8 0.6433
OSCc 0.775 (0.69, 0.86) 0.0154 0.7333 0.3764
KCd 0.712 (0.626, 0.798) 0.361 0.8333 0.5984
TRCe 0.679 (0.589, 0.770) 0.69 0.8333 0.5169
a ABI any side of ankle brachial index <0.9 was defined as abnormal. b MNSI
Michigan Neuropathy Screening Instrument: normal <2 c OSC Optimal scaling
combination: normal <7.6 d KC: King’s college classification: normal <2 e TRC
University Texas risk classification system: normal <2.
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health variables
We have shown a strong relationship between MNSI and
ABI. KC and TRC are clinically significant diabetic foot
ulcer classification systems. The significant relationship be-
tween MNSI and KC, and MNSI and TRC, demonstrate
that MNSI is a useful screening tool for preventing DFP.
Systolic blood pressure is a known indicator associated with
vascular damage in diabetic disease. Meanwhile, diabetic-
related health variables, such as blood glucose, LDL, and
WC, are positively associated with the severity of diabetic
neuropathy. These relationships have been demonstrateda MNSI: Michigan Neuropathy Screening Instrument
b OSC: Optimal scaling combination of MNSI and age
Figure 2 The ROC curves for the identification of ABI with KC,
TRC, and MNSI.with Pearson or Spearman correlation coefficients in a
similar way in this study.
ROC for the prediction of the results of ABI is higher if
OSC is used
Aging is a known indicator in the development of DFP
[34]. This association was evident in our study to show
the importance of both in vascular and nerve function.
MNSI is the most cost-effective community screening
tool for peripheral neurological assessment and ABI is
the first-line study assessing peripheral vascular function.
However, age is an important indicator that should be
considered before using MNSI or ABI as an indicator,
because aging can increase the risk of developing DFP.
Combining data on age and MNSI more closely corre-
lates with the ABI for rural community diabetes. In fact,
the use of only ABI or MNSI for all individuals may lead
to an underestimation of DFP in the elderly.
To diagnosis DFP, we propose the use of OSC as a
useful screening indicator for identifying an optimal cut-
off point. Table 4 results show that the AUC for the pre-
diction of the results of ABI among rural community
diabetes is higher when OSC is used. Since finding a
simple screening method for DFP was the major purpose
of this study, it was important to determine which indi-
cator was the most effective for ABI assessment. Figure 2
and Table 4 show ROC curves and sensitivity as well as
specificity for the identification of the results of ABI
evaluation, with cut-off values for MNSI, OSC, KC, and
TRC. Note that, the optimal cut-off values (MNSI ≥2,
and KC, TRC >1) are the same as the original criteria from
previous references. The OSC showed a higher ROC
curve and a balance of sensitivity and specificity for the
prediction of the abnormal ABI, which are 80.0% and
64.3%, respectively. This result implies that age is a core
criteria for DPF in rural community diabetes.
Conclusions
We have investigated the relationships between the non-
invasive tools of MNSI, ABI, and diabetic-related health
variables, and to prevent early diabetic foot problems
among rural community diabetic patients. This study
has four principal findings: (1) MNSI is correlated with
vascular function and diabetic-related health variables;
(2) ABI is associated with peripheral nerve function and
health variables; (3) this is the first study to combine age
with MNSI as a new index (OSC) to evaluate peripheral
nerve function; and (4) using MNSI and OSC as com-
munity screening tools, because they are cost-effective
and useful in preventing DFP.
MNSI, OSC, KC, and TRC are useful screening tools for
revealing the incidence of peripheral neurovasculopathy
or DFP among the elderly. ABI is the most useful objective
variable in assessing problems with arterial blockage
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tion of the results of ABI evaluation, we suggest that
OSC is a better predictor of DFP in the elderly. OSC
cut-off points can be converted into a consumer-
friendly table (Additional file 1). The results of this
study suggest that primary healthcare providers should
apply OSC to screen and improve poor health and life-
styles in elderly diabetics in rural communities. Since
we knew the argument of false negative in accuracy, we
studied the correlation with the MNSI and OSC of
MNSI to evaluate the ABI role on screening in rural
population. Probably for the next step, we will apply
other tools to obtain the quantitative data, such as skin
perfusion pressure. Further research should consider
other ethnicities and self-management intervention for
elderly diabetics in rural communities since this could
be a valuable procedure for improving their health.
Additional file
Additional file 1: Reference table for OSC.
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